Steve Miller, Chief Operating Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 7,933 shares at $1.80 ($14K) on 2016-01-11, disclosed to the SEC on 2016-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2024-08-22 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |